Form and Function Finally Prove Mitchell's Proton Motive Force

Volume 16 | Issue 13 | 28 | Jun. 24, 2002 Previous | Next Form and Function Finally Prove Mitchell's Proton Motive Force Perseverance, perspiration and a creative bent pay off | By Susan Jenkins The Faculty of 1000 is aWeb-based literature awareness tool published by BioMed Central. For more information visit www.facultyof1000.com. In 1961, Nobel laureate Peter Mitchell's provocative pairing of

Written bySusan Jenkins
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In 1961, Nobel laureate Peter Mitchell's provocative pairing of chemistry and biology gave birth to his chemiosmotic hypothesis and its corollary proton motive force, or what Mitchell liked to call proticity.1 Forty years later, the authors of these two selected Faculty of 1000 papers2,3 have provided structural and functional confirmation of Mitchell's theories.

In the first paper, So Iwata and his graduate student Mika Jormakka provide molecular proof of proton motive force and an energy conserving redox loop,2 another Mitchell proposal. In the second manuscript, Andreas Matouschek and colleague Shihai Huang3 describe mitochondrial chemiosmosis and proton motive force in action. "It's a very, very old story," says Iwata, "and most of it came from Mitchell's imagination."

Mitchell's theory, known as the chemiosmotic hypothesis, envisioned that positively charged hydrogen ions (protons) were transferred from one membrane side to the other, and that this process involved electron transfer reactions and adenosine triphosphate ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform